Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amil Madhukar Shah, M.D.

Co-Author

This page shows the publications co-authored by Amil Shah and Scott Solomon.
Connection Strength

26.849
  1. Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study. Circulation. 2017 01 31; 135(5):426-439.
    View in: PubMed
    Score: 0.689
  2. Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study. Circulation. 2017 Jan 17; 135(3):224-240.
    View in: PubMed
    Score: 0.687
  3. Valvular heart disease in older adults: seeking an ounce of prevention. Eur Heart J. 2016 12 14; 37(47):3523-3524.
    View in: PubMed
    Score: 0.676
  4. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail. 2015 Nov; 8(6):1052-8.
    View in: PubMed
    Score: 0.636
  5. Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly. Circulation. 2015 Nov 24; 132(21):1979-89.
    View in: PubMed
    Score: 0.632
  6. Mechanical Dyssynchrony: A Risk Factor but not a Target. Eur Heart J. 2016 Jan 01; 37(1):60-2.
    View in: PubMed
    Score: 0.631
  7. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circulation. 2015 Aug 04; 132(5):402-14.
    View in: PubMed
    Score: 0.623
  8. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail. 2014 Sep; 7(5):740-51.
    View in: PubMed
    Score: 0.586
  9. Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging. 2014 Jan; 7(1):173-81.
    View in: PubMed
    Score: 0.556
  10. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure. JACC Cardiovasc Imaging. 2012 Nov; 5(11):1139-46.
    View in: PubMed
    Score: 0.518
  11. Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J. 2012 Jul; 33(14):1716-7.
    View in: PubMed
    Score: 0.506
  12. Myocardial deformation imaging: current status and future directions. Circulation. 2012 Jan 17; 125(2):e244-8.
    View in: PubMed
    Score: 0.491
  13. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur J Heart Fail. 2012 Feb; 14(2):185-92.
    View in: PubMed
    Score: 0.481
  14. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. Am Heart J. 2011 Oct; 162(4):685-91.
    View in: PubMed
    Score: 0.479
  15. The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension. J Hypertens. 2011 Sep; 29(9):1829-36.
    View in: PubMed
    Score: 0.478
  16. The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail. 2010 Nov; 12(11):1229-37.
    View in: PubMed
    Score: 0.451
  17. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. Am J Cardiol. 2010 Oct 01; 106(7):911-6.
    View in: PubMed
    Score: 0.444
  18. A unified view of ventricular remodelling. Eur J Heart Fail. 2010 Aug; 12(8):779-81.
    View in: PubMed
    Score: 0.443
  19. Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure. J Am Coll Cardiol. 2022 02 01; 79(4):355-368.
    View in: PubMed
    Score: 0.246
  20. Apolipoprotein E Polymorphism, Cardiac Remodeling, and Heart Failure in the ARIC Study. J Card Fail. 2021 Dec 26.
    View in: PubMed
    Score: 0.244
  21. Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life. J Am Heart Assoc. 2021 12 07; 10(23):e020094.
    View in: PubMed
    Score: 0.243
  22. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2021 08 03; 10(15):e019545.
    View in: PubMed
    Score: 0.238
  23. Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life. J Card Fail. 2021 12; 27(12):1382-1392.
    View in: PubMed
    Score: 0.237
  24. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans. Eur J Heart Fail. 2021 08; 23(8):1290-1295.
    View in: PubMed
    Score: 0.235
  25. Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans. J Am Coll Cardiol. 2021 07 06; 78(1):89-91.
    View in: PubMed
    Score: 0.234
  26. Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life. JAMA Cardiol. 2021 05 01; 6(5):509-520.
    View in: PubMed
    Score: 0.234
  27. Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction. Int J Cardiol. 2021 07 15; 335:59-65.
    View in: PubMed
    Score: 0.233
  28. Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis. PLoS Med. 2020 10; 17(10):e1003361.
    View in: PubMed
    Score: 0.225
  29. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure. Hypertension. 2020 09; 76(3):808-818.
    View in: PubMed
    Score: 0.220
  30. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail. 2020 08; 8(8):640-653.
    View in: PubMed
    Score: 0.220
  31. Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF. J Am Coll Cardiol. 2020 03 31; 75(12):1501-1502.
    View in: PubMed
    Score: 0.217
  32. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. J Am Coll Cardiol. 2019 12 10; 74(23):2858-2873.
    View in: PubMed
    Score: 0.212
  33. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. Circulation. 2020 02 04; 141(5):338-351.
    View in: PubMed
    Score: 0.211
  34. Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial. Eur J Heart Fail. 2020 03; 22(3):557-559.
    View in: PubMed
    Score: 0.210
  35. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults. JAMA Cardiol. 2019 10 01; 4(10):997-1006.
    View in: PubMed
    Score: 0.209
  36. The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2019 10; 21(10):1207-1215.
    View in: PubMed
    Score: 0.207
  37. Application of the H2 FPEF score to a global clinical trial of patients with heart failure with preserved ejection fraction: the TOPCAT trial. Eur J Heart Fail. 2019 10; 21(10):1288-1291.
    View in: PubMed
    Score: 0.206
  38. Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2019 08; 7(8):664-675.
    View in: PubMed
    Score: 0.206
  39. Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study. JAMA Netw Open. 2019 06 05; 2(6):e195321.
    View in: PubMed
    Score: 0.205
  40. Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study. JAMA Cardiol. 2019 05 01; 4(5):466-472.
    View in: PubMed
    Score: 0.203
  41. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 2019 01 22; 139(4):431-443.
    View in: PubMed
    Score: 0.200
  42. HFE H63D Polymorphism and the Risk for Systemic Hypertension, Myocardial Remodeling, and Adverse Cardiovascular Events in the ARIC Study. Hypertension. 2019 01; 73(1):68-74.
    View in: PubMed
    Score: 0.199
  43. Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk. J Am Coll Cardiol. 2018 10 09; 72(15):1763-1773.
    View in: PubMed
    Score: 0.196
  44. IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure. Circ Heart Fail. 2018 10; 11(10):e005133.
    View in: PubMed
    Score: 0.195
  45. Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol. 2018 10 01; 3(10):939-948.
    View in: PubMed
    Score: 0.195
  46. Declining Lung Function and Cardiovascular Risk: The ARIC Study. J Am Coll Cardiol. 2018 09 04; 72(10):1109-1122.
    View in: PubMed
    Score: 0.194
  47. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018 09; 3(9):e419-e428.
    View in: PubMed
    Score: 0.194
  48. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial. JACC Heart Fail. 2018 08; 6(8):689-697.
    View in: PubMed
    Score: 0.192
  49. Adiposity, body composition and ventricular-arterial stiffness in the elderly: the Atherosclerosis Risk in Communities Study. Eur J Heart Fail. 2018 08; 20(8):1191-1201.
    View in: PubMed
    Score: 0.189
  50. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study. JAMA Cardiol. 2018 03 01; 3(3):200-206.
    View in: PubMed
    Score: 0.187
  51. Ideal Cardiovascular Health and the Prevalence and Severity of Aortic Stenosis in Elderly Patients. J Am Heart Assoc. 2018 02 03; 7(3).
    View in: PubMed
    Score: 0.187
  52. Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance. Circ Heart Fail. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.184
  53. Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2017 Sep 22; 6(9).
    View in: PubMed
    Score: 0.182
  54. Left ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort. Eur J Heart Fail. 2018 07; 20(7):1106-1114.
    View in: PubMed
    Score: 0.181
  55. Cardiovascular Dysfunction and Frailty Among Older Adults in the Community: The ARIC Study. J Gerontol A Biol Sci Med Sci. 2017 Jul 01; 72(7):958-964.
    View in: PubMed
    Score: 0.179
  56. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist). Circulation. 2017 Sep 12; 136(11):982-992.
    View in: PubMed
    Score: 0.179
  57. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial. JACC Heart Fail. 2017 04; 5(4):241-252.
    View in: PubMed
    Score: 0.176
  58. An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality. J Am Heart Assoc. 2017 Mar 24; 6(4).
    View in: PubMed
    Score: 0.176
  59. Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction. Eur J Heart Fail. 2017 08; 19(8):1043-1052.
    View in: PubMed
    Score: 0.176
  60. Age- and Sex-Related Influences on Left Ventricular Mechanics in Elderly Individuals Free of Prevalent Heart Failure: The ARIC Study (Atherosclerosis Risk in Communities). Circ Cardiovasc Imaging. 2017 Jan; 10(1).
    View in: PubMed
    Score: 0.173
  61. Diastolic Dysfunction and Hypertension. Med Clin North Am. 2017 Jan; 101(1):7-17.
    View in: PubMed
    Score: 0.173
  62. Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study. JACC Heart Fail. 2017 03; 5(3):157-165.
    View in: PubMed
    Score: 0.173
  63. Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities). Circ Cardiovasc Imaging. 2016 Sep; 9(9):e004950.
    View in: PubMed
    Score: 0.169
  64. Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities). Circ Heart Fail. 2016 08; 9(8).
    View in: PubMed
    Score: 0.168
  65. Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study. Eur Heart J. 2016 Aug 21; 37(32):2544-51.
    View in: PubMed
    Score: 0.165
  66. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2016 Apr; 9(4):e002763.
    View in: PubMed
    Score: 0.164
  67. Influence of cigarette smoking on cardiac biomarkers: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2016 06; 18(6):629-37.
    View in: PubMed
    Score: 0.164
  68. Left Atrial Structure and Function Across the Spectrum of Cardiovascular Risk in the Elderly: The Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging. 2016 Feb; 9(2):e004010.
    View in: PubMed
    Score: 0.162
  69. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2016 May; 39(5):677-85.
    View in: PubMed
    Score: 0.162
  70. Right Atrial Function in Pulmonary Arterial Hypertension. Circ Cardiovasc Imaging. 2015 Nov; 8(11):e003521; discussion e003521.
    View in: PubMed
    Score: 0.160
  71. Prehypertension is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study. Am J Hypertens. 2016 May; 29(5):568-74.
    View in: PubMed
    Score: 0.158
  72. Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”. Circ Heart Fail. 2015 Sep; 8(5):1010.
    View in: PubMed
    Score: 0.158
  73. Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study. Circulation. 2015 Oct 06; 132(14):1329-37.
    View in: PubMed
    Score: 0.158
  74. Relationship between alcohol consumption and cardiac structure and function in the elderly: the Atherosclerosis Risk In Communities Study. Circ Cardiovasc Imaging. 2015 Jun; 8(6).
    View in: PubMed
    Score: 0.155
  75. American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function. Am J Med. 2015 Sep; 128(9):970-6.e2.
    View in: PubMed
    Score: 0.154
  76. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study. Circ Heart Fail. 2015 May; 8(3):448-54.
    View in: PubMed
    Score: 0.153
  77. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J. 2015 Apr 14; 36(15):939-45.
    View in: PubMed
    Score: 0.151
  78. The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med. 2015 Jan 01; 372(1):21-9.
    View in: PubMed
    Score: 0.151
  79. Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease. J Hypertens. 2014 Dec; 32(12):2479-86; discussion 2486-7.
    View in: PubMed
    Score: 0.150
  80. Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension. Eur J Heart Fail. 2015 Jan; 17(1):63-73.
    View in: PubMed
    Score: 0.149
  81. Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF? J Am Coll Cardiol. 2014 Oct 07; 64(14):1535-6.
    View in: PubMed
    Score: 0.148
  82. Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail. 2014 Oct; 2(5):447-54.
    View in: PubMed
    Score: 0.147
  83. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014 Sep 02; 130(10):820-8.
    View in: PubMed
    Score: 0.147
  84. Reply from the authors. Am J Respir Crit Care Med. 2014 Apr 01; 189(7):869-70.
    View in: PubMed
    Score: 0.143
  85. Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension. Eur Heart J. 2015 Mar 07; 36(10):623-32.
    View in: PubMed
    Score: 0.142
  86. Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function. J Hypertens. 2014 Jan; 32(1):174-80.
    View in: PubMed
    Score: 0.141
  87. Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med. 2013 Dec 15; 188(12):1460-5.
    View in: PubMed
    Score: 0.140
  88. Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities). JACC Heart Fail. 2013 Dec; 1(6):531-6.
    View in: PubMed
    Score: 0.140
  89. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail. 2014 Jan; 7(1):104-15.
    View in: PubMed
    Score: 0.139
  90. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. Eur Heart J. 2014 Jan; 35(1):42-7.
    View in: PubMed
    Score: 0.139
  91. Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities study. Hypertension. 2013 Sep; 62(3):492-8.
    View in: PubMed
    Score: 0.136
  92. Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study. JACC Heart Fail. 2013 Apr; 1(2):156-63.
    View in: PubMed
    Score: 0.133
  93. Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency. Eur Heart J. 2013 Mar; 34(9):676-83.
    View in: PubMed
    Score: 0.128
  94. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012 Oct 20; 380(9851):1387-95.
    View in: PubMed
    Score: 0.128
  95. Functional strain-line pattern in the human left ventricle. Phys Rev Lett. 2012 Jul 27; 109(4):048103.
    View in: PubMed
    Score: 0.127
  96. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012 Feb 15; 307(7):674-84.
    View in: PubMed
    Score: 0.123
  97. Regional right ventricular strain pattern in patients with acute pulmonary embolism. Echocardiography. 2012 Apr; 29(4):464-70.
    View in: PubMed
    Score: 0.123
  98. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Eur Heart J. 2011 May; 32(10):1227-34.
    View in: PubMed
    Score: 0.115
  99. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010 Sep 07; 122(10):985-92.
    View in: PubMed
    Score: 0.111
  100. Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia. JAMA. 2022 03 22; 327(12):1138-1148.
    View in: PubMed
    Score: 0.062
  101. Cardiac Structure and Function and Diabetes-Related Risk of Death or Heart Failure in Older Adults. J Am Heart Assoc. 2022 03 15; 11(6):e022308.
    View in: PubMed
    Score: 0.062
  102. Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas. Int J Cardiol. 2022 Apr 01; 352:78-83.
    View in: PubMed
    Score: 0.062
  103. Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in Communities Study. Eur Heart J Cardiovasc Imaging. 2022 01 24; 23(2):283-293.
    View in: PubMed
    Score: 0.061
  104. Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF. J Am Heart Assoc. 2021 12 07; 10(23):e021494.
    View in: PubMed
    Score: 0.061
  105. Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study. J Am Heart Assoc. 2021 11 02; 10(21):e021723.
    View in: PubMed
    Score: 0.060
  106. Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2021 11; 14(11):e008293.
    View in: PubMed
    Score: 0.060
  107. Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study. J Clin Hypertens (Greenwich). 2021 10; 23(10):1887-1896.
    View in: PubMed
    Score: 0.060
  108. Heart failure associated with imported malaria: a nationwide Danish cohort study. ESC Heart Fail. 2021 10; 8(5):3521-3529.
    View in: PubMed
    Score: 0.059
  109. Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study. Int J Cardiol. 2021 Sep 15; 339:47-53.
    View in: PubMed
    Score: 0.059
  110. Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection Fraction and Sex. Circ Heart Fail. 2021 03; 14(3):e007891.
    View in: PubMed
    Score: 0.058
  111. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21.
    View in: PubMed
    Score: 0.057
  112. High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study. Clin Chem. 2021 01 08; 67(1):298-307.
    View in: PubMed
    Score: 0.057
  113. Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC-PET Study. J Am Heart Assoc. 2020 12 15; 9(24):e018399.
    View in: PubMed
    Score: 0.057
  114. Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study. J Am Heart Assoc. 2020 10 20; 9(19):e014669.
    View in: PubMed
    Score: 0.056
  115. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study. J Am Heart Assoc. 2020 07 07; 9(13):e015405.
    View in: PubMed
    Score: 0.055
  116. Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC-NCS. J Am Heart Assoc. 2019 12 03; 8(23):e013197.
    View in: PubMed
    Score: 0.053
  117. Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study". Circulation. 2019 11 12; 140(20):e772-e773.
    View in: PubMed
    Score: 0.053
  118. Associations Between Left Ventricular Structure, Function, and Cerebral Amyloid: The ARIC-PET Study. Stroke. 2019 12; 50(12):3622-3624.
    View in: PubMed
    Score: 0.052
  119. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. JAMA. 2019 Sep 17; 322(11):1085-1095.
    View in: PubMed
    Score: 0.052
  120. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. JAMA. 2019 Sep 17; 322(11):1077-1084.
    View in: PubMed
    Score: 0.052
  121. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 2019 06 04; 139(23):2642-2653.
    View in: PubMed
    Score: 0.051
  122. Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score. Circulation. 2019 01 08; 139(2):180-191.
    View in: PubMed
    Score: 0.050
  123. Associations of Echocardiography Markers and Vascular Brain Lesions: The ARIC Study. J Am Heart Assoc. 2018 12 18; 7(24):e008992.
    View in: PubMed
    Score: 0.050
  124. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. N Engl J Med. 2018 Jul 05; 379(1):22-31.
    View in: PubMed
    Score: 0.048
  125. Widening Racial Differences in Risks for Coronary Heart Disease. Circulation. 2018 03 13; 137(11):1195-1197.
    View in: PubMed
    Score: 0.047
  126. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.047
  127. Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005961.
    View in: PubMed
    Score: 0.047
  128. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Circ Heart Fail. 2018 03; 11(3):e004457.
    View in: PubMed
    Score: 0.047
  129. Weight History and Subclinical Myocardial Damage. Clin Chem. 2018 01; 64(1):201-209.
    View in: PubMed
    Score: 0.046
  130. High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2017 10; 19(10):1303-1309.
    View in: PubMed
    Score: 0.045
  131. Racial Disparities in Risks of Stroke. N Engl J Med. 2017 05 25; 376(21):2089-2090.
    View in: PubMed
    Score: 0.044
  132. Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function. Blood. 2017 02 09; 129(6):799-801.
    View in: PubMed
    Score: 0.043
  133. Hemodynamic Correlates of Blood Pressure in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study. J Clin Hypertens (Greenwich). 2016 12; 18(12):1222-1227.
    View in: PubMed
    Score: 0.042
  134. Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction. Eur Heart J. 2016 Feb 01; 37(5):466-72.
    View in: PubMed
    Score: 0.040
  135. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2015 Apr; 65(4):550-8.
    View in: PubMed
    Score: 0.037
  136. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail. 2014 Nov; 7(6):953-9.
    View in: PubMed
    Score: 0.037
  137. Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014 Oct; 16(10):1096-103.
    View in: PubMed
    Score: 0.037
  138. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2014 Nov 01; 114(9):1368-72.
    View in: PubMed
    Score: 0.037
  139. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J. 2014 Dec 21; 35(48):3442-51.
    View in: PubMed
    Score: 0.036
  140. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014 May; 16(5):535-42.
    View in: PubMed
    Score: 0.035
  141. Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT trial. Circ Heart Fail. 2014 Jan; 7(1):154-60.
    View in: PubMed
    Score: 0.035
  142. Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J. 2014 Jun 07; 35(22):1457-65.
    View in: PubMed
    Score: 0.035
  143. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014 Feb 11; 63(5):447-56.
    View in: PubMed
    Score: 0.035
  144. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Heart Rhythm. 2013 Dec; 10(12):1770-7.
    View in: PubMed
    Score: 0.034
  145. Comparative numerical study on left ventricular fluid dynamics after dilated cardiomyopathy. J Biomech. 2013 Jun 21; 46(10):1611-7.
    View in: PubMed
    Score: 0.034
  146. Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy. Circ Heart Fail. 2013 May; 6(3):435-42.
    View in: PubMed
    Score: 0.033
  147. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT. J Card Fail. 2013 Mar; 19(3):149-55.
    View in: PubMed
    Score: 0.033
  148. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT. Heart Rhythm. 2013 Mar; 10(3):354-60.
    View in: PubMed
    Score: 0.033
  149. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012 Dec; 164(6):902-9.e2.
    View in: PubMed
    Score: 0.032
  150. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012 Aug; 14(8):931-8.
    View in: PubMed
    Score: 0.031
  151. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011 Jul; 32(14):1720-9.
    View in: PubMed
    Score: 0.029
  152. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail. 2011 Jul; 4(4):433-40.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.